Vaccine Procurement: A Conceptual Framework Based on Literature Review.
Europe
immunization
review
vaccine
vaccine procurement
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
03 Dec 2021
03 Dec 2021
Historique:
received:
02
11
2021
revised:
27
11
2021
accepted:
30
11
2021
entrez:
28
12
2021
pubmed:
29
12
2021
medline:
29
12
2021
Statut:
epublish
Résumé
Ensuring timely access to affordable vaccines has been acknowledged as a global public health priority, as also recently testified by the debate sparked during the COVID-19 pandemic. Effective vaccine procurement strategies are essential to reach this goal. Nevertheless, this is still a neglected research topic. A narrative literature review on vaccine procurement was conducted, by retrieving articles from four academic databases (PubMed/MEDLINE, Scopus, Embase, WebOfScience), 'grey' literature reports, and institutional websites. The aim was to clarify key concepts and definitions relating to vaccine procurement, describe main vaccine procurement methods, and identify knowledge gaps and future perspectives. A theoretical conceptual framework was developed of the key factors involved in vaccine procurement, which include quality and safety of the product, forecasting and budgeting, procurement legislation, financial sustainability, and plurality of manufacture, contracting, investment in training, storage and service delivery, monitoring and evaluation. This information can be useful to support policymakers during planning, implementation, and evaluation of regional and national vaccine procurement strategies and policies.
Identifiants
pubmed: 34960180
pii: vaccines9121434
doi: 10.3390/vaccines9121434
pmc: PMC8707219
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Vaccine. 2013 Apr 18;31 Suppl 2:B73-80
pubmed: 23598495
Vaccine. 2016 Sep 22;34(41):4998-5004
pubmed: 27576077
Vaccine. 2015 Jan 1;33(1):52-61
pubmed: 24300593
Lancet. 2021 Jan 2;397(10268):8-10
pubmed: 33308484
Vaccine. 2015 Mar 24;33(13):1541-8
pubmed: 25444788
Vaccine. 2013 Nov 4;31(46):5314-20
pubmed: 24055304
Res Integr Peer Rev. 2019 Mar 26;4:5
pubmed: 30962953
Public Health Rep. 2007 Nov-Dec;122(6):811-6
pubmed: 18051674
Expert Rev Vaccines. 2020 Feb;19(2):123-132
pubmed: 31990601
Ann Ig. 2020 Jul-Aug;32(4):430-432
pubmed: 32744301
Nature. 2018 Mar;555(7694):30
pubmed: 32094876
Hum Vaccin Immunother. 2016 Aug 2;12(8):2038-2045
pubmed: 27224429
Soc Sci Med. 2012 Nov;75(9):1572-80
pubmed: 22835922
Expert Rev Vaccines. 2014 Jul;13(7):843-54
pubmed: 24865112
Vaccine. 2017 Apr 19;35(17):2121-2126
pubmed: 28364919
Bull World Health Organ. 2008 Feb;86(2):140-6
pubmed: 18297169
Global Health. 2014 May 08;10:34
pubmed: 24885767
Risk Anal. 2016 Jul;36(7):1487-509
pubmed: 25109229
Vaccine X. 2019 Jul 18;2:100033
pubmed: 31384748
Vaccine. 2017 Mar 1;35(9):1209-1210
pubmed: 26657186
Vaccine. 2019 Sep 20;37(40):5909-5919
pubmed: 31447125
Front Immunol. 2018 Jan 18;9:26
pubmed: 29403503
Vaccine. 2002 Jan 15;20(7-8):1000-3
pubmed: 11803059
Vaccine. 2018 Jul 16;36(30):4582-4588
pubmed: 29929825
Lancet. 2004 Jan 10;363(9403):134
pubmed: 14733192
Cell. 2019 Sep 19;179(1):13-17
pubmed: 31519310
Int Health. 2019 Mar 1;11(2):79-80
pubmed: 30551179
N Engl J Med. 2016 Jul 28;375(4):301-3
pubmed: 27276108
PLoS One. 2014 Feb 20;9(2):e89593
pubmed: 24586899